We have Ranked, Sorted and Summarized the Latest Clinical Articles.

1Post-diagnostic statin use and the risk of lethal prostate cancer in the Health Professionals Follow-up StudyCancer Epidemiology, Biomarkers & Prevention, July 27, 2015  Clinical Article
2Incidental prostate cancer diagnosis during holmium laser enucleation: Assessment of predictors, survival, and disease progressionUrology, July 27, 2015  Clinical Article
3Detection of prostate cancer index lesions with multiparametric MRI (mp-MRI) using whole-mount histological sections as the reference standardBJU International, July 27, 2015  Clinical Article
4Efficacy and safety of rezum system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasiaUrology, July 27, 2015  Clinical Article
5Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinomaInternational Journal of Clinical Oncology, July 27, 2015  Clinical Article
6Automated computed tomography–ultrasound cross-modality 3-d contouring algorithm for prostateUltrasound in Medicine and Biology, July 27, 2015  Clinical Article
7Prostate diffusion imaging with distortion correctionMagnetic Resonance Imaging, July 27, 2015  Clinical Article
8ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancerJournal of Clinical Pathology, July 27, 2015  Clinical Article
9Diffusion weighted imaging of prostate cancer: Effect of b-value distribution on repeatability and cancer characterizationMagnetic Resonance Imaging, July 27, 2015  Clinical Article
10Da vinci and open radical prostatectomy: Comparison of clinical outcomes and analysis of insurance costsUrologia Internationalis, July 27, 2015  Clinical Article

Show Me:

We have Ranked, Sorted and Summarized the Latest Clinical Articles.

1For prostate cancer patients, risk-specific therapies now more the normUCSF News, July 27, 2015
2Investigating the role of enzymes in pelvic painNorthwestern Medicine News, July 23, 2015
3Dr. Ervin K. Kocjancic treats first patient with the UroLift SystemUniversity of Illinois Hospital & Health Sciences System, July 23, 2015
4Genomic fingerprint may predict aggressive prostate cancer in African AmericansThomas Jefferson University News, July 22, 2015
5Sensor technology can improve accuracy of prostate cancer diagnosisUniversity of Birmingham Medical News, July 17, 2015
6New role for prostate cancer protein could lead to better diagnosis and treatmentCancer Research UK News, July 17, 2015
7Increased radiation dose offers no survival benefit for patients with low-risk prostate cancer, Penn study findsPenn Medicine, July 17, 2015
8Fruitfly sperm cells reveal intricate coordination in stem cell replication, Penn study findsPenn Medicine, July 16, 2015
9Noted urologist calls attention to implications of flawed prostate specific antigen data in SEERAmerican Urological Association News, July 16, 2015
10Kidney, bladder stones do not increase postmenopausal women’s risk of osteoporosisGeorgia Regents University & Health System News, July 15, 2015

Show Me:

GALNT4 predicts survival in patients with ccRCC

As reported in the Journal of Urology, N-acetylgalactosaminyltransferase 4 (GALNT4) levels are decreased in tumor specimens from patients with clear cell renal cell carcinoma (ccRCC; n=104) compared to peritumoral specimens. Decreased expression of GALNT4 is associated with poor OS (OR=3.08) and RFS (OR=2.17). Further, GALNT4 is negatively correlated with tumor size, necrosis, and TNM stage.

PCA3 useful for early diagnosis of prostate cancer

Based on a meta-analysis reported in the Chinese Medical Journal, prostate cancer antigen 3 (PCA3) can be used for the early diagnosis of prostate cancer and to avoid unnecessary biopsies, with a sensitivity of 0.82, a specificity of 0.962, a positive likelihood ratio of 2.39, a negative likelihood ratio of 0.51, and a diagnostic odds ratio of 4.89.

High expression of MUC1 + HER3 is associated with favorable outcome in bladder cancer patients

As reported in BJU International, elevated co-expression of MUC1 + HER3 was associated with improved survival in patients with bladder cancer. MUC1 alone, or elevated MUC1 + non-elevated HER3, had no prognostic value. Moreover, MUC1 was not predictive of survival, tumor stage, or tumor grade.

Are YOU the Smartest Doc in America?

The Smartest Doc from MDLinx keeps you current with a competitive edge, pitting colleagues against one other for the title of The Smartest Doc in America.

Take the Challenge

Clinical Pearls

Clinical Pearl from Smartest DocConventional two-stage hepatectomy may be the safest resection method in patients with colorectal cancer liver metastases.

Clinical Pearl from Smartest DocA trained canine olfactory system can detect prostate cancer-specific volatile organic compounds in urine samples.

Clinical Pearl from Smartest DocMaintenance BCG is the recommended treatment for high-risk non-muscle-invasive bladder cancer.

Clinical Articles in Urology

MDLinx Urology News

Search today's latest urology news, updated daily from over 2,000 peer-reviewed journals, at MDLinx. Stay current with up-to-the-minute reproductive information and urinary related clinical research covering all aspects of the male and female urinary tract system and the male reproductive organs. Our diligent team of MDLinx physician editors rigorously research a wide range of urology medical journals dedicated to the kidney, bladder, penis, urethra and prostate as well as pediatric urology, prostate cancer, kidney stones, infections and sexually transmitted diseases (STDs), urologic imaging, ureteral disorders, voiding and incontinence, infertility and laparoscopy. They then summarize and rank the articles by clinical impact to provide the most valuable literature to make sure any urologist, and all members of their healthcare team, can stay current with the latest in neurological clinical research.